DNA Sequencing Market to Reach Valuation of USD 12.6 Billion by 2028 – Growth in Prevalence of Cancer and Genetic Disorders Drives the Market

In terms of revenue, the Global DNA Sequencing Market is expected to reach USD 12.6 Billion by 2028, growing at a CAGR (Compound Annual Growth Rate) of 17.30% from 2022 to 2028.

The future trends in personalized genomics to treat different diseases, genetic disorders, advancements in DNA Sequencing procedures, and the growing incidence of cancers and pre-natal & neo-natal disorders contribute significantly to the DNA Sequencing Market.

DNA Sequencing has brought a standard change in proteomic and genomic research because it is a highly accurate and high-throughput technology used for several applications such as DNA resequencing, de novo assembly, and whole-genome sequencing (WGS). Therefore, this technology is implemented readily in numerous academic research institutes for research studies.

Key Highlights from Report:

· Among Products, the Consumables segment dominated the DNA Sequencing Market with the highest market share and will continue to lead during the forecast period. This is due to the extensive availability of reagents and kits to supply library construction steps like DNA fragmentation, amplification, enrichment, adapter ligation, and quality control.

· Based on the Technology, the Next-Generation Sequencing segment accounted for the highest CAGR in the coming years. This growth is attributed to the increase in the rate of novel viral diseases and the ongoing research & development activity in DNA Sequencing.

· North America holds the largest market share and will likely be the most profitable market in the forecast period. This surge is because of the growth in the adoption of highly developed technologies and encouraging support from the government and associated policies in this region.

Market Dynamics

DNA Sequencing has high accuracy and speed, is cost-effective, and the outcome can be derived even from low samples. The DNA Sequencing Market garners extensive increases from its execution in varied applications such as microarray and other global analysis methods. DNA Sequencing technologies have been advanced from the 1st generation to the 3rd generation, gaining much traction owing to their features. This will likely fuel the DNA Sequencing Market.

The rapid developments in sequencing technology and bioinformatics enable the identification of DNA variations. These developments also determine variants related to the augmented risk for disease. Furthermore, a high range of genes can be tested in a single diagnostic platform simultaneously with the extensive application of Next-generation Sequencing (NGS) and Whole-genome Sequencing (WGS) that expands the efficacy of DNA Sequencing in clinical diagnosis applications. All these factors are likely to propel the market’s growth. Also, in biomarker and cancer segments, the application of DNA Sequencing will possibly create profitable prospects for the DNA Sequencing Market in the coming years due to the surging prevalence and incidence of cancer worldwide.

However, the high expenditure of establishing and maintaining a sequencing facility and the need for more skilled professionals might hamper the market growth.

Geographically, {Largest_Region}} market is expected to witness the most extensive market growth with a significant growth rate during the forecast period. The region’s market growth can be attributable to various critical factors like the increasing demand for genome sequencing by well-developed research and healthcare facilities, the surge in need for personalized medicines, and high adoption rates of novel & advanced technology. In addition, the United States is a significant contributor to this regional market owing to the growing funding and support activities of government and non-government bodies. Also, there has been a positive blow to this regional market because of the outbreak of COVID-19. Moreover, the presence of significant market participants, the abundance of academic & research institutes, and the availability of technologically advanced products will contribute to the market’s development in North America.

The Global DNA Sequencing Market is Segmented as follows:

• Product
  • Instruments
  • Consumables
  • Services
• Technology
  • Third Generation DNA Sequencing
  • Next-Generation Sequencing
  • Sanger Sequencing
• Application
  • Clinical Investigation
  • Oncology
  • Forensics & Agri-Genomics
  • Reproductive Health
  • HLA Typing
  • Other Applications
• End-Use
  • Clinical Research
  • Academic Research
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Clinics
  • Other End-Uses
• Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

List of the Key Players of the Global DNA Sequencing Market is:

Agilent Technologies, Illumina Inc., QIAGEN, Perkin Elmer, Thermo Fisher Scientific, Hoffmann-La Roche Ltd., Macrogen Inc., Bio-Rad Laboratories Inc., Oxford Nanopore Technologies Ltd., Myriad Genetics

The Global DNA Sequencing Market Scope can be Tabulated as below: